BRIEF-Merck to record $2.9 bln impairment charge related to uprifosbuvir program - SEC filing

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.